Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Mandel, Katharina ^a   Seidl, Daniel ^b   Rades, Dirk ^b   Lehnert, Hendrik ^b   Gieseler, Frank ^b   Hass, Ralf ^a   Ungefroren, Hendrik ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; GELATINASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ARTICLE; BREAST CANCER; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHEMOKINESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; REAL TIME CELL ANALYSIS;

BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOLOGICAL TECHNIQUES; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84874013087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056591     Document Type: Article

References (38)

1. Porter PL, (2009) Global trends in breast cancer incidence and mortality. Salud Publica Mex 51 Suppl 2: s141-146.
2. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624-1633.
3. Klein CA, (2008) The metastasis cascade. Science 321(5897):: 1785-1787.
4. McSherry EA, Donatello S, Hopkins AM, McDonnell S, (2007) Molecular basis of invasion in breast cancer. Cell Mol Life Sci 64: 3201-3218.
5. Lavrentieva A, Majore I, Kasper C, Hass R, (2010) Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 8: 18.
6. Brábek J, Mierke CT, Rösel D, Vesely P, Fabrý B, (2010) The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal 8: 22.
7. Calorini L, Bianchini F, (2010) Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. Cell Commun Signal 8: 24.
8. Majore I, Moretti P, Hass R, Kasper C, (2009) Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 7: 6.
9. Hass R, Kasper C, Böhm S, Jacobs R, (2011) Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9: 12.
10. Hass R, Otte A, (2012) Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal 10: 26.
11. Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R, (2011) Interaction of tumor cells with the microenvironment. Cell Commun Signal 9: 18.
12. Alexander S, Friedl P, (2012) Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Trends Mol Med 18: 13-26.
13. Friedl P, Alexander S, (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009.
14. Drabsch Y, ten Dijke P, (2011) TGF-β signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia 16: 97-108.
15. Harbeck N, Kates RE, Schmitt M, (2002) Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination. J Clin Oncol 20: 1000-1007.
16. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, et al. (2009) Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9: 20.
17. Jezierska A, Motyl T, (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15: RA32-40.
18. Radisky ES, Radisky DC, (2010) Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212.
19. Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H, et al. (2011) The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat 128: 657-666.
20. Hass R, Bertram C, (2009) Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. J Exp Clin Cancer Res 28: 127.
21. Chaturvedi S, Hass R, (2011) Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech Ageing Dev 132: 213-219.
22. Keese CR, Bhawe K, Wegener J, Giaever I, (2002) Real-time impedance assay to follow the invasive activities of metastatic cells in culture. Biotechniques 33: 842-844, 846, 848-850.
23. Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, et al. (2012) Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 7: e46536.
24. Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F, (2011) Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells. Int J Oncol 38: 797-805.
25. Ungefroren H, Groth S, Sebens S, Lehnert H, Gieseler F, et al. (2011) Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer 10: 67.
26. Bartscht T, Lehnert H, Gieseler F, Ungefroren H, (2012) The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells. Cancer Chemother Pharmacol 70: 221-230.
27. Bertram C, Hass R, (2009) Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Mech Aging Dev 30: 657-669.
28. Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, et al. (2011) Management of phyllodes breast tumors. Breast J 17: 129-137.
29. Gieseler F, Stelck B, Blume LF, Denker M, Dohrmann P, et al. (2007) [Coagulation and formation of malignant effusions]. Hamostaseologie 27: 273-277.
30. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.
31. Ungefroren H, Krull NB, (1996) Transcriptional regulation of the human biglycan gene. J Biol Chem 271: 15787-15795.
32. Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, et al. (2007) Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene 26: 4850-4862.
33. Sweep CG, Geurts-Moespot J, Grebenschikov N, de Witte JH, Heuvel JJ, et al. (1998) External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer 78: 1434-1441.
34. Schmitt M, Sturmheit AS, Welk A, Schnelldorfer C, Harbeck N, (2006) Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA. Methods Mol Med 120: 245-265.
35. Wang SJ, Saadi W, Lin F, Minh-Canh Nguyen C, Li Jeon N, (2004) Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 300: 180-189.
36. Lv ZD, Kong B, Li JG, Qu HL, Wang XG, et al. (2013) Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncol Rep 29: 219-225.
37. Bartsch JE, Staren ED, Appert HE, (2003) Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392.
38. Taylor MA, Parvani JG, Schiemann WP, (2010) The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 15: 169-190.